To Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Escalating Single and Multiple Doses of KP104
Clinical trial NCT05490017 · COMPLETED
Trial details
- NCT number
- NCT05490017
- Sponsor
- Kira Pharmacenticals (US), LLC.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-30
- Primary completion
- 2022-05-04
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.